Residual Impairments in Treated Ocd Patients - Edna Foa

Abstract

Funding Agency

Agency: National Institute of Health (NIH)
Institute: National Institute of Mental Health (NIMH)
Type: Unknown (R10)
Project #: 3R10MH045404-06S1
Application #: 2878063
Study Section: Special Emphasis Panel (ZMH1-CRB-W (17))

Project Start: 1990-09-01
Project End: 1998-11-10
Budget Start: 1998-01-01
Budget End: 1998-11-10
Support Year: 6
Fiscal Year: 1998
Total Cost
Indirect Cost

Institution

Name: Allegheny University of Health Sciences
Department: Psychiatry
Type: Schools of Medicine
DUNS #

City: Philadelphia
State: PA
Country: United States
Zip Code: 19129

Related projects


NIH 1999 R10 MH	Clomipramine and Behavior Therapy in Ocd Foa, Edna B. / Mcp Hahnemann University
NIH 1999 R10 MH	Clomipramine and Behavior Therapy in Ocd Foa, Edna B. / University of Pennsylvania
NIH 1998 R10 MH	Clomipramine and Behavior Therapy in Ocd Foa, Edna B. / Allegheny University of Health Sciences
NIH 1998 R10 MH	Residual Impairments in Treated Ocd Patients Foa, Edna B. / Allegheny University of Health Sciences
NIH 1998 R10 MH	Clomipramine and Behavior Therapy in Ocd Foa, Edna B. / Mcp Hahnemann University
NIH 1997 R10 MH	Clomipramine and Behavior Therapy in Ocd Foa, Edna B. / Allegheny University of Health Sciences

Publications

Simpson, Helen Blair; Foa, Edna B; Liebowitz, Michael R et al. (2013) Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial. JAMA Psychiatry 70:1190-9

Huppert, Jonathan D; Simpson, H Blair; Nissenson, Kore J et al. (2009) Quality of life and functional impairment in obsessive-compulsive disorder: a comparison of patients with and without comorbidity, patients in remission, and healthy controls. Depress Anxiety 26:39-45

Comments

Be the first to comment on this grant